According to a new study in Iowa, offering the abortion pill (mifepristone, or RU-486) remotely has just as an effective outcome as offering it through an in-person visit, including a high satisfaction level of their experience:

Three-quarters of patients who choose that option said they did not prefer having the doctor in the room during the procedure that allows physicians to remotely supervise administration of the pregnancy-ending drug RU-486.

Ninety-four percent of the women who chose telemedicine reported that they were “very satisfied” with the procedure, and researchers found that women who received “virtual” counseling had no more complications than those who had office visits, according to the new report published in the ...